Sign In
Buy DXCM
$72.77
-0.680 (-0.93%)
At Close: Jun 03, 2026
2 Best Stocks to Buy in January and Hold Forever
10:09am, Friday, 13'th Jan 2023
The new year is here, and with it, more opportunities to invest in wonderful companies.
As Dexcom Settles, 2 Option Strategies Collect Premium, Minimize Risk
03:41pm, Wednesday, 11'th Jan 2023
Let's consider a combination of two strategies involving options with the goal being to collect as much premium upfront and minimizing our risk. The post As Dexcom Settles, 2 Option Strategies Collect
DexCom (DXCM) Announces Solid Preliminary Q4 Revenues
02:18pm, Tuesday, 10'th Jan 2023
DexCom's (DXCM) revenue growth in the fourth quarter is likely to have been boosted by continued strength in its CGM sales.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio (Revised)
05:16am, Friday, 06'th Jan 2023
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
3 Reasons to Hold DexCom (DXCM) Stock in Your Portfolio
01:32pm, Thursday, 05'th Jan 2023
Investors continue to be optimistic about DexCom (DXCM) owing to its strong product portfolio.
Have $2,000 to Invest? 2 Top Stocks That Could Go Parabolic
10:35am, Friday, 30'th Dec 2022
Stocks with long-term growth potential abound even in the current market.
12 Stocks Turned $10,000 To $277,126 In 12 Months
08:00am, Friday, 30'th Dec 2022
Most S&P 500 investors lost nearly 20% this year. But plenty of moneymaking stocks jumped higher.
Jefferies Makes Massive 2023 Changes to ‘Strong Buy' Franchise List of Top Stock Picks
07:23am, Thursday, 22'nd Dec 2022
All the companies that we follow here at 24/7 Wall St. keep a curated list for their institutional and high net worth retail clients of their highest conviction stock picks.
2 Breakout Growth Stocks to Buy for the Long Haul
09:45am, Thursday, 15'th Dec 2022
These growing businesses are just starting to see the beginning of their long-term potential.
Can FDA Approval Bolster DexCom, Inc.?
10:33am, Wednesday, 14'th Dec 2022
Dexcom is relying on the interest and sales of its new continuous glucose monitor--which recently received FDA approval--to boost revenue (and stock value).
FDA Clears New Continuous Glucose Monitor From Dexcom
05:27pm, Friday, 09'th Dec 2022
One of our favorite CGM systems is getting an upgrade. The G7 is smaller than the G6, takes less time to warm up and comes with an improved app and alerts.
Dexcom Flirts With Breakout After FDA Clears Next-Gen Diabetes Device
09:50am, Thursday, 08'th Dec 2022
Dexcom stock jumped Thursday after the FDA cleared its next-generation continuous glucose monitor for patients with diabetes. The post Dexcom Flirts With Breakout After FDA Clears Next-Gen Diabetes De
3 Supercharged Growth Stocks to Buy for 2023
05:23am, Thursday, 01'st Dec 2022
Next year could be a very important one for all three of these fast-growing businesses.
Eleven Stocks Turned $10,000 To $261,421 In 11 Months
08:00am, Wednesday, 30'th Nov 2022
Most S&P 500 investors got a little gain this month. But investors willing to look off the beaten path found huge gains.
These Are the Five Best and Worst Performing Healthcare Stocks in October 2022
08:02pm, Monday, 28'th Nov 2022
The healthcare sector has gained momentum following the COVID-19 pandemic. Several companies gained early regulatory approval for developing COVID-19 drugs and distributing vaccines.
